The Damon Runyon Cancer Research Foundation is thrilled to continue our partnership with the Timmerman Traverse, an adventurous initiative that brings leaders and investors in biotech together to scale extraordinary heights. Biotech journalist, entrepreneur, and mountaineer Luke Timmerman will lead a team of scientific luminaries who will hike to Everest Base Camp in April 2025, while aiming to raise at least $700,000 to benefit Damon Runyon cancer researchers. To learn more about the team of intrepid climbers and how to support their fundraising, visit damonrunyon.org/traverse.

The 2024 Traverse to the summit of Mt. Kilimanjaro raised nearly $1.2 million for Damon Runyon.